Twitter | Search | |
Search Refresh
Julia Simard, ScD Nov 27
is there a one or two word term that refers to physician’s adherence to treatment guidelines?
Reply Retweet Like
Henrik Stovring Feb 1
The box with my printed dissertation has arrived. Write me a mail if you want a copy.
Reply Retweet Like
rachel lynch 28 Aug 16
Great spotlight session - vaccine ADRs topic for ?
Reply Retweet Like
Jenny Lund 21h
Replying to @ProfMattFox
I think this might be substantive area-specific. In , we often focus very carefully on study design (eg, new user designs, active comparators, etc) as an upfront effort to mitigate bias.
Reply Retweet Like
Elena Dudukina Jun 15
I had simply the best time at summer school. Huge thanks to for making it possible, teaching professors for sharing their knowledge and motivating us, and to all fellow participants for being passionate about science and so easy-going
Reply Retweet Like
Amandine Gouverneur 25 Aug 16
Interesting conference in room Hall 1 about Dealing with unmeasured covariates
Reply Retweet Like
Médicaments&Grossesse Aug 26
Last poster exhibit from our team at ! Come visit Maelle Dandjinou at the spotlight poster A! “Antidepressant hse in pregnancy and the risk of gestational diabetes mellitus”
Reply Retweet Like
CMAJ 24 Aug 15
CMAJ Deputy Editor is at Mon thru Wed this week. Seek her out if interested in publishing in CMAJ
Reply Retweet Like
Daloha Rodríguez-M. Jun 11
I'm at the Pharmacoepidemiology Summer School organized by the Department of Clinical Epidemiology from the University of Aarhus and will be here all week learning awesome things about
Reply Retweet Like
Drug Safety Research Jan 8
Our service for smaller companies levels the playing field between large pharma and SMEs. Contact us at any stage of your post-authorisation journey. We work with you to find the best model for you. This case study shows how it works:
Reply Retweet Like
ARD & RMD Open 29 Aug 16
Missed opportunities to reduce exposure to drugs associated with fracture risk
Reply Retweet Like
Simon Horsburgh Nov 20
From use in pregnancy to access. Interesting work by exploring how to achieve elimination of access inequities by 2025.
Reply Retweet Like
Sarah Donald Aug 23
Really useful workshop at looking at minimising biases in different study types for pregnancy . Thanks to all presenters for a great morning!
Reply Retweet Like
HealthCore Aug 25
Learn more about the benefits of to identify patterns in big data and target patients with improved positive predictive value and sensitivity at .
Reply Retweet Like
Elena Dudukina Jun 13
Another day at summer school looks good: cracking meta-analysis ‘code’ (all thanks to prof. dr Olaf Dekkers), warm-up with practical exercise using STATA or R (really appreciate the flexibility), and refreshing time afterwards.
Reply Retweet Like
Dr Claire Wylie Aug 22
On my way to to present a research protocol for my first foray into pharmacoepidemiology
Reply Retweet Like
Sarah Donald Jul 25
2. Medicine use in pregnancy is increasing – this is of concern because many medicines lack evidence of safety during pregnancy. Cohort studies using large health databases can explore safety issues quickly, cheaply & ethically.
Reply Retweet Like
Optum 24 Aug 15
's David Dore presents to attendees research
Reply Retweet Like
Dr Monica Koo 10 Jun 15
Liam Murray: the repositioning, reprofiling, retasking of drugs is increasingly relevant to treatment
Reply Retweet Like
Francesco Salvo Sep 28
Sushi time for in practice. The crude cannot lie. ⁦
Reply Retweet Like